US Broker Ratings

Nyxoah SA (NYXH) Stock Analysis: Exploring a 209% Potential Upside in the Medical Device Sector

Nyxoah SA (NASDAQ: NYXH), a Belgium-based medical technology company, is gaining attention in the healthcare sector with its innovative approach to treating obstructive sleep apnea. The..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: A Bold 403% Upside Potential Amid Clinical Innovations

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is drawing significant attention from investors, thanks to its promising pipeline in the biotechnology sector and an eye-catching potential upside of..

Sanara MedTech Inc. (SMTI) Investor Outlook: Navigating a 6.45% Potential Upside in the Healthcare Sector

Sanara MedTech Inc. (NASDAQ: SMTI), a key player in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its..

Mereo BioPharma Group plc (MREO) Stock Analysis: Exploring a Potential 566.97% Upside in Biotech

Mereo BioPharma Group plc (NASDAQ: MREO) is capturing investor attention with its substantial potential upside of 566.97%, as highlighted by recent analyst ratings. This UK-based biotechnology..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Navigating a Clinical-Stage Biotech with a Strategic Focus on Genetically Defined Diseases

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is a clinical-stage biopharmaceutical company that has carved out a niche in the healthcare sector by developing small molecules aimed at..

Canopy Growth Corporation (CGC): Investor Outlook on Potential 37.76% Upside

Investors eyeing the cannabis sector have likely encountered Canopy Growth Corporation (NASDAQ: CGC), a Canadian-based firm that has positioned itself as a significant player in the..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Navigating Challenges in the Medical Device Sector

SANUWAVE Health, Inc. (SNWV), a player in the healthcare sector specializing in medical devices, is drawing attention with its innovative approach to regenerative medicine. The company’s..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unlocking a 387% Upside Potential in Biotech

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical company specializing in therapies for women’s cancers, is presenting a compelling investment opportunity with a staggering potential upside..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield Raises Investor Eyebrows

Spok Holdings, Inc. (NASDAQ: SPOK) has captured the attention of investors with its notably generous dividend yield of 12.28%, an aspect that stands out in the..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Potential 122% Upside in the Healthcare Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) presents a compelling opportunity for investors seeking exposure to the burgeoning medical devices sector. Operating within the healthcare industry, the company’s..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 59% Upside in the Biotech Arena

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector with its ambitious focus on precision oncology, particularly targeting the RAS/MAPK pathway-driven cancers. With a..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Challenges Amidst Volatile Market Conditions

Zhengye Biotechnology Holding L (ZYBT), a niche player in the healthcare sector, is making strides in the competitive drug manufacturing industry with a focus on specialty..

Evolent Health, Inc (EVH) Stock Analysis: Unveiling a 26.93% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) stands at the forefront of healthcare innovation, offering a unique investment opportunity with a compelling 26.93% potential upside, according to analyst..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 5.63% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a prominent player in the biotechnology industry, is making waves with its innovative approach to treating autoimmune diseases. With a market..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthcare Growth Story with 10% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its promising growth trajectory and robust analyst support. With a market capitalization..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Over 400% Potential Upside with Strong Buy Ratings

Structure Therapeutics Inc. (NASDAQ: GPCR) stands out in the biotechnology sector with a remarkable potential upside of over 400%, according to analysts. As a clinical-stage biopharmaceutical..

Establishment Labs Holdings Inc (ESTA): Analyst Consensus Predicts Nearly 50% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA), a burgeoning player in the medical device industry, is capturing investor attention with a compelling growth narrative and significant upside..

Mineralys Therapeutics, Inc. (MLYS): Investor Outlook with a 125% Potential Upside and Strong Buy Ratings

Mineralys Therapeutics, Inc. (MLYS), a promising player in the biotechnology sector, is making waves in the healthcare industry with its cutting-edge approach to tackling cardiorenal conditions...

Artivion, Inc. (AORT) Stock Analysis: Exploring a 78% Potential Upside in the Medical Devices Sector

Artivion, Inc. (AORT) stands as a prominent player in the healthcare sector, specifically within the niche of medical devices. Headquartered in Kennesaw, Georgia, Artivion is a..

agilon health, inc. (AGL) Stock Analysis: Navigating Healthcare with a 28.22% Potential Upside

agilon health, inc. (NYSE: AGL) is carving a niche in the healthcare sector, specifically in medical care facilities, by delivering specialized services to seniors through primary..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds